Cygenica
1 known investors
Find your way into Cygenica
CyGenica develops a targeted intracellular drug delivery technology, the GEENIE platform, to deliver therapeutic molecules into cells more safely and efficiently. Its work focuses on treatments for oncology and rare genetic diseases, serving biopharmaceutical companies developing therapies.
Investors · 1
Frequently asked questions
- What does Cygenica do?
- CyGenica develops a targeted intracellular drug delivery technology, the GEENIE platform, to deliver therapeutic molecules into cells more safely and efficiently. Its work focuses on treatments for oncology and rare genetic diseases, serving biopharmaceutical companies developing therapies.
- Who are Cygenica's investors?
- Cygenica's investors include Golden Sparrow Ventures, Llc.